Chief Projects Coordinator
Since October 2014
Independent Consultant for the biotech/vaccine industry
Since April 2014
Director - Head Biologicals Competitive Intelligence
April 2008 --- July 2013
Creation of the competitive intelligence organization at GSK Biologicals: - design of overall structure, modus operandi and reporting; - selection and implementation of CI tools (agencies, databases, IT tools, ...) Day-to-day running the CI network Preparation of analyses and reports.
Director - Head Project Management Pediatric franchise
April 2006 --- April 2008
Responsible of the project management team covering vaccine projects in late development (HSV), or in life cycle (Rotavirus, DTP combinations portfolio, hepatitis A & B portfolio, MMRV). In coordination with Franchise Head and Commercial Strategy Head, define global strategy of the Franchise and products/projects.
Associate Director - R&D Partnerships
March 2004 --- March 2006
Set-up of a new structure within R&D for extramural early research to identify, select and follow potential new collaborations. Project Management of Dengue vaccine project. In collaboration with Walter Reed Army Institute of Research (Bethesda, USA) and AFRIMS (Bangkok, Thailand) Project management of CMV and VZV vaccine projects.
Associate Director - Vaccines for Emerging Diseases
November 2001 --- February 2004
Leader of Tuberculosis and Chlamydia trachomatis vaccine projects at GSKBio: scientific leadership; coordination of activities between several GSK Bio departments (R&D, clinical, regulatory, Corporate Intellectual Property, Legal, Business Development) and outside collaborator (Corixa - US). In charge of extramural activities, interactions with the Intellectual Property and Business Development departments for the Vaccine for Emerging Diseases (VED) Department.
Associate Director - Head of Preclinical Immunology - Bacterial Vaccines
January 2000 --- November 2001
In charge of preclinical evaluation of bacterial vaccines, development of immunological assays and animal models with a team of 30 employees (4 PhD, 6 MS, technicians). Follow-up outside collaborations in bacterial vaccine development. Set-up and management of the R&D, Business Development, Corporate Intellectual Property interface: proposal and follow-up of patent filings and strategies; participation to in-licensing process.
Associate Director - Extramural R&D
March 1995 --- December 1999
Scientific interactions with research groups (academic, industry, government) outside of SmithKline Beecham Biologicals: identification, evaluation of proposal, initiation and follow-up of collaborations. Main area: bacterial vaccines. Set-up of outside contacts database; involvement in definition of in-licensing process.
Scientist - Molecular Biology
December 1989 --- March 1995
Responsible of the molecular biology (expression, site-directed mutagenesis, variability analysis, ...) for the development of recombinant vaccines against Bordetella pertussis (whooping cough), Borrelia burgdorferi (Lyme disease) and Neisseria meningitidis.
April 1987 --- December 1989
PhD in from Université catholique de Louvain in 1987
in Bioengineering from Université catholique de Louvain in 1982